NEW YORK (Reuters Health) – The glucagon-like peptide 1 analog taspoglutide administered subcutaneously once weekly improves glycemic control and reduces body weight in drug-naive patients with type 2…
NEW YORK (Reuters Health) – Most domains of health-related quality of life in iron-deficient patients with chronic heart failure improve significantly after 4 weeks of treatment with intravenous…
NEW YORK (Reuters Health) – There is less risk of growth failure in human milk-fed premature infants when they’re given a human milk fortifier with extra protein, Australian…
NEW YORK (Reuters Health) – If lifestyle changes are not enough to control type 2 diabetes, metformin should be the first oral agent added to treatment, according to…
NEW YORK (Reuters Health) – A French team concludes that routine neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) should be discontinued for preterm infants,…
NEW YORK (Reuters Health) – Children with egg-induced anaphylaxis can safely receive the influenza vaccine, according to findings published in the January 9th Journal of Allergy and Clinical…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who don’t have retinopathy at baseline have a relatively low risk of developing eye complications during 5 to…
NEW YORK (Reuters Health) – H1N1 antibody levels remain high in children a year after immunization with a monovalent adjuvanted pandemic swine influenza vaccine, a UK team reports…
NEW YORK (Reuters Health) – Untreated gastroesophageal reflux does not appear to be a factor in poorly controlled asthma in children, as adding a proton pump inhibitor to…
NEW YORK (Reuters Health) – Hyperprolactinemia is a relatively common cause of secondary amenorrhea in young women with menstruation irregularities, Korean researchers report in a December 19th on-line…